Regen Medical Gains Investors In …
We are delighted to announce that Investors in People has awarded the Joint Operations Family (Joint Operations (UK) LLP, …
The JWC Masterclass on skin subst…
The debate on Skin Substitutes
There is no doubt that there is further debate to be had on wound care versus wound healin…
Acceptance evaluation of an impre…
Background: Effective debridement is an essential component of the treatment of complex wounds (Frykberg and Banks, 2015)….
Nanomedic’s Spincare gun sprays w…
A copy of the article from the Times By Tom Knowles
Monday April 05 2021, 12.01am EST, The Times
The device uses a laser …
6 reasons that make it easier to …
Cryopreserved allograft burns skin is normally reserved for larger burns. Working with our partners AlloSource we have fou…
Level 1 study – EpiFix demonstrat…
EpiFix has demonstrated in previous studies very high rates of healing, with the original study showing 90%+ rates of heal…
Inside NEXA – disposable NP…
Nexa has re-invented disposable NPWT: The first & only multi-patient, multi-week NPWT system with three new & uniq…
#Selfcare at home
#Selfcare and wound healing, not wound management: New & simple to implement options
Our products support you with deb…
EpiFix dHACM amniotic tissue R…
With new technologies the question is often asked, where does it fit in? With the case of Amniotic Tissue and EpiFix® and …
Using amniotic tissue dHACM allog…
Bill Tettelbach talks about using Amniotic Tissue in the treatment of chronic wounds. This article is based on a talk give…
The use of Epiprotect®, an advanc…
An opportunity to take an early look at a new pilot series looking at EpiProtect and Nexobrid in Paediatrics
A final versi…
Supply of PPE
As a well-established UK medical distributor, Regen Medical have been able to procure PPE through our European manufacturi…
COVID-19 Statement
Following the updated Government guidelines on COVID-19 I am writing to inform you that as suppliers to the NHS and privat…
The solution to hard to heal wounds
What do you do if you haven’t achieved 40-50% closure at 4 weeks?
At Wounds UK Leanne Atkin and Bill Tettelbach will be sh…
Placental based Allografts
Placental Based Allografts are now being acknowledged more and more as a potential treatment in non healing and hard to he…
Microbial Cellulose (Epiprotect®)…
The team at Children’s Burns and Plastics,Nottingham Children’s Hospital were the first to try and adopt EpiProtect® here …
EpiFix dHACM Amniotic Tissue R…
Attendees at the recent Charing Cross Symposium in London had the opportunity to hear Leanne Atkin, Vascular Nurse Consult…
A case series using DHACM allogra…
This early case series from the Welsh Wound Innovation Centre looks at some of the first patients in the UK to receive Epi…
Joint Operations welcomes two loc…
The last few months have seen many exciting developments at Joint Operations, a Swindon based medical device distribution …
Regenerative Medicine – The…
What is regenerative medicine?
Regenerative medicine is the science of replacing, engineering or regenerating human cells,…
HTA licence approved Joint Operat…
HTA licence approved for Joint Operations.
Joint Operations operates in several specialities which utilise human tissue fo…